INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
Stanford University
Stanford, Estados UnidosPublicaciones en colaboración con investigadores/as de Stanford University (31)
2024
2022
-
A 6-mRNA host response classifier in whole blood predicts outcomes in COVID-19 and other acute viral infections
Scientific Reports, Vol. 12, Núm. 1
2021
-
Fuzzy Matching for Cellular Signaling Networks in a Choroidal Melanoma Model
Advances in Intelligent Systems and Computing
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials
Leukemia, Vol. 35, Núm. 1, pp. 18-30
-
NADPH oxidase 4 (Nox4) deletion accelerates liver regeneration in mice
Redox Biology, Vol. 40
-
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
The Lancet Oncology, Vol. 22, Núm. 3, pp. e105-e118
-
Virtual Reality During Brain Mapping for Awake-Patient Brain Tumor Surgery: Proposed Tasks and Domains to Test
World Neurosurgery, Vol. 152, pp. e462-e466
2019
-
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
European Journal of Immunology, Vol. 49, Núm. 10, pp. 1457-1973
-
LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL
Cancer Cell, Vol. 36, Núm. 3, pp. 237-249.e6
-
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions
Haematologica, Vol. 104, Núm. 10, pp. 1935-1949
-
STS, ESTS and JACS survey on surveillance practices after surgical resection of lung cancer
Interactive cardiovascular and thoracic surgery, Vol. 29, Núm. 4, pp. 532-538
-
Society for Translational Medicine Expert consensus on the selection of surgical approaches in the management of thoracic esophageal carcinoma
Journal of Thoracic Disease, Vol. 11, Núm. 1, pp. 319-328
2018
-
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
The Lancet Oncology, Vol. 19, Núm. 9, pp. 1192-1204
2017
-
Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions
Oncotarget, Vol. 8, Núm. 43, pp. 73483-73500
2016
-
Complete response to gemtuzumab ozogamicin in a patient with refractory mast cell leukemia
Leukemia
-
Dietary and microbiome factors determine longevity in Caenorhabditis elegans
Aging, Vol. 8, Núm. 7, pp. 1513-1539
-
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356
Autophagy
-
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy, Vol. 12, Núm. 1, pp. 1-222